Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human Serpin A4/Kallistatin DuoSet ELISA, 15 Plate
antitrypsin), member 4
KAL
Kallistatin
KLST
KSTKallikrein inhibitor
member 4
PI-4
PI4Peptidase inhibitor 4
protease inhibitor 4 (kallistatin)
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase
Serpin A4
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin)
Background
The human serpin superfamily consists of at least 35 members that target not only serine proteases, but also selected cysteine proteases and non-protease proteins. Serpins bind the protease active site resulting in a major conformational rearrangement that traps the enzyme in a covalent acyl-enzyme intermediate. As protease inhibitors, serpins have an array of functions including regulating blood clotting, the complement pathway, extracellular matrix remodeling, and cell motility. They are also involved in activities that extend beyond their ability to inhibit proteases. For instance, they may also regulate blood pressure, angiogenesis, or act as storage/transport proteins.
Bioinformatics Tool for Serpin A4/Kallistatin (DY1669)
Discover related pathways, diseases and genes to Serpin A4/Kallistatin (DY1669). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Serpin A4/Kallistatin (DY1669)
Discover more about diseases related to Serpin A4/Kallistatin (DY1669).
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.